MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome

H. Fujita, K. Suzuki, Y. Watanabe, M. Hamaguchi, K. Hirata (Mibu, Japan)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease

L-A. Leyland, R. Mahmood, R. Weil (London, United Kingdom)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Validation of the ‘ecological momentary assessment’ (EMA) method as a tool for daily life monitoring in patients with Parkinson’s disease

J. Habets, M. Heijmans, C. Herff, C. Simons, A. Leentjens, Y. Temel, M. Kuijf, P. Kubben (Maastricht, Netherlands)

Phenomenology and Clinical Assessment of Movement Disorders  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

SJ. Kim (Busan, Republic of Korea)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment

M. Todisco, P. Vitali, B. Minafra, F. Avantaggiato, R. Zangaglia, NG. Pozzi, R. Ceravolo, C. Pacchetti (Pavia, Italy)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity

S. Gutierrez, K. Aveni, A. Torani, A. Roberts (Evanston, IL, USA)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
VIM stimulation for refractory tremor -the Sheba experience

V. Livneh, S. Korn, G. Yaalom, T. Karmon, H. Strauss, Z. Zibly, R. Spiegelmann, S. Baer (Tel Aviv, Israel)

Surgical Therapy  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley